3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Solid Tumors
2
Ovarian Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Vaginal Neoplasms
1
Triple-negative Metastatic Breast Cancer
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdomyosarcoma
1
Previously Treated Non Small Cell Lung Cancer
1
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
1
Pinealoma
1
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic-Myeloproliferative Diseases
1
Metastatic Pancreatic Adenocarcinoma
1
Meningeal Carcinomatosis
1
Medulloblastoma
1
Lymphoid Interstitial Pneumonia
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Interventions
Oxaliplatin
49
Fluorouracil
45
Leucovorin
42
Capecitabine
40
Irinotecan
31
Bevacizumab
31
Radiotherapy
24
Cetuximab
23
Radiation
13
Panitumumab
13
Folfox protocol
10
Surgical Procedures, Operative
9
IFL protocol
8
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
aflibercept
5
Immunohistochemistry
5
Gene Expression Profiling
5
Chemotherapy, Adjuvant
5
Fluorodeoxyglucose F18
4
Floxuridine
4
Celecoxib
4
trifluridine tipiracil drug combination
3
dehydroftorafur
3
XELOX
3
Sorafenib
3
Ramucirumab
3
Neoadjuvant Therapy
3
Erlotinib Hydrochloride
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Rectal Neoplasms
×
adavosertib
×
Clear all
No trials found.